Citations (6)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Susanne Bürki, Evgenii Shumilov, Nicolas Bonadies, Johanna Flach, Myriam Legros, Yara Banz, Elisabeth Oppliger-Leibundgut, Martin Fiedler, Anne Angelillo-Scherrer, Alicia Rovo & Ulrike Bacher. (2018) Coincidence of 5q deletion and the JAK2V617F mutation: report of two patients with overlapping myelodysplastic and myeloproliferative features and review of the literature. Leukemia & Lymphoma 59:9, pages 2233-2237.
Read now
Read now
Satoko Oka, Kazuo Ono & Masaharu Nohgawa. (2017) Myelodysplastic syndrome with concomitant del(5q) and JAK2 V617F mutation transformed to acute myeloid leukemia with an additional chromosomal abnormality after a long-term treatment with lenalidomide. Leukemia & Lymphoma 58:10, pages 2511-2513.
Read now
Read now
Pellegrino Musto, Vittorio Simeon, Roberto Guariglia, Gabriella Bianchino, Vitina Grieco, Filomena Nozza, Francesco La Rocca, Gioacchino Marziano, Anna Vittoria Lalinga, Emiliano Fabiani, Maria Teresa Voso, Patrizia Scaravaglio, Cristina Mecucci & Giovanni D’Arena. (2014) Myelodysplastic disorders carrying both isolated del(5q) and JAK2 mutation: concise review, with focus on lenalidomide therapy. OncoTargets and Therapy 7, pages 1043-1050.
Read now
Read now
Articles from other publishers (3)
Keita Kirito. (2020) Myeloid neoplasm with isolated del(5q) and the MPLW515L mutation fulfills the WHO diagnostic criteria for ET. International Journal of Hematology 112:2, pages 238-242.
Crossref
Crossref
Eleftheria Hatzimichael, Konstantinos Lagos, Amalia Vassou, Dora Gougopoulou, Alexandra Papoudou‑Bai & Evangelos Briasoulis. (2016) Durable response to lenalidomide in a patient with myelodysplastic syndrome associated with isolated�5q deletion and JAK2 V617F mutation despite discontinuation of treatment. Molecular and Clinical Oncology.
Crossref
Crossref
Meritxell Nomdedeu, Margherita Maffioli, Xavier Calvo, Alejandra Mart?nez-Trillos, Tycho Baumann, Marina D?az-Bey?Josep-Llu?s Aguilar, Mar?a Rozman, Dolors Costa, Jordi Esteve, Francisco Cervantes, Dolors Colomer & Benet Nomdedeu. (2011) Efficacy of lenalidomide in a patient with myelodysplastic syndrome with isolated del(5q) and JAK2V617F mutation. Leukemia Research 35:9, pages 1276-1278.
Crossref
Crossref